MedPath

HADASSAH MEDICAL ORGANIZATION (CC)

๐Ÿ‡ฎ๐Ÿ‡ฑIsrael
Ownership
-
Employees
-
Market Cap
-
Website

Alveolar Bone Loss Around 3 Different Designs of Dental Implant: Prospective Comparative Clinical Trail

Not Applicable
Conditions
Alveolar Bone Loss
First Posted Date
2007-10-16
Last Posted Date
2009-02-03
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
25
Registration Number
NCT00544323
Locations
๐Ÿ‡ฎ๐Ÿ‡ฑ

Hadassah medical center, school of dentistry, Jerusalem, Israel

Bio-availability of a New Liquid Tumeric Extract

Phase 1
Withdrawn
Conditions
Healthy
First Posted Date
2007-10-11
Last Posted Date
2015-08-20
Lead Sponsor
Hadassah Medical Organization
Registration Number
NCT00542711
Locations
๐Ÿ‡ฎ๐Ÿ‡ฑ

Hadassah Medical Organization, Jerusalem, Israel

Comparative Results of Conservatively and Surgically Treated Adolescents With Triplane and Juvenile Tillaux Ankle Fractures After Skeletal Maturity

Terminated
Conditions
Ankle Injuries
First Posted Date
2007-10-10
Last Posted Date
2011-09-16
Lead Sponsor
Hadassah Medical Organization
Registration Number
NCT00541580

Evaluation of Diprospan Injection to the Knee on Rehabilitation of Patients After TKR of the Contralateral Knee

Phase 4
Completed
Conditions
Osteoarthritis
Interventions
Drug: Bupivocaine
First Posted Date
2007-10-10
Last Posted Date
2008-11-11
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
50
Registration Number
NCT00542139
Locations
๐Ÿ‡ฎ๐Ÿ‡ฑ

Hadassah Medical Organization, Jerusalem, Israel

Ephedrine for the Treatment of Congenital Myasthenia

Phase 1
Conditions
Myasthenic Syndromes, Congenital
First Posted Date
2007-10-10
Last Posted Date
2007-10-10
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
15
Registration Number
NCT00541216
Locations
๐Ÿ‡ฎ๐Ÿ‡ฑ

Hadassah Medical Organization, Jerusalem, Israel, Jerusalem, Israel

Transient Osteoporosis of Pregnancy: A Possible Peptide Mediator

Suspended
Conditions
Transient Osteperosis
First Posted Date
2007-10-10
Last Posted Date
2008-03-18
Lead Sponsor
Hadassah Medical Organization
Registration Number
NCT00541645

Effectiveness of the Selective Serotonin Reuptake Inhibitor,Citalopram (Cipralex), in Prurigo Nodularis

Not Applicable
Conditions
Prurigo Nodularis
First Posted Date
2007-09-20
Last Posted Date
2007-09-20
Lead Sponsor
Hadassah Medical Organization
Registration Number
NCT00532519
Locations
๐Ÿ‡ฎ๐Ÿ‡ฑ

: Hadassah Medical Organization,, Jerusalem, Israel

Evaluation of the Dental Health Condition in Obesity Patients Before and After Bariatric Surgery

Conditions
Obesity
Periodontitis
Caries
Periapical Lesion
First Posted Date
2007-09-18
Last Posted Date
2007-09-18
Lead Sponsor
Hadassah Medical Organization
Registration Number
NCT00531154
Locations
๐Ÿ‡ฎ๐Ÿ‡ฑ

Hadassah Medical Organization, Jerusalem, Israel

Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD

Phase 1
Conditions
Hematological Malignancies
Graft Versus Host Disease
Interventions
Biological: ApoCell
First Posted Date
2007-09-05
Last Posted Date
2015-06-11
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
12
Registration Number
NCT00524784
Locations
๐Ÿ‡ฎ๐Ÿ‡ฑ

Department of Bone Marrow Transplantation, Jerusalem, Israel

Phase I Clinical Trial to Assess Safety of UV Phototherapy for the Prevention of GVHD Post Allogeneic SCT

Phase 1
Withdrawn
Conditions
Allogeneic Transplantation (Non T-cell Depleted)
Interventions
Device: EUMATRON - EN 600 NT
First Posted Date
2007-09-05
Last Posted Date
2015-06-11
Lead Sponsor
Hadassah Medical Organization
Registration Number
NCT00524953
Locations
๐Ÿ‡ฎ๐Ÿ‡ฑ

Hadassah Medical Organization, Jerusalem, Israel

ยฉ Copyright 2025. All Rights Reserved by MedPath